4,477 results match your criteria Transjugular Liver Biopsy


[Life-threatening bleeding from ileal conduit venous varices in a patient with portal hypertension].

Urologe A 2018 Dec 11. Epub 2018 Dec 11.

Radiologische Klinik, Universitätsklinikum Bonn, Sigmund-Freud-Straße 25, 53127, Bonn, Deutschland.

Life-threatening bleeding from portosystemic varices is a feared complication of portal hypertension. Particularly, varices in atypical locations-so-called ectopic varices-pose a challenge for diagnosis and therapy. In the present article, we describe the case of a patient with liver cirrhosis and recurrent bleeding from an ileal conduit resulting from peristomal varicosis. Read More

View Article
December 2018

Transjugular percutaneous endovascular treatment of dysfunctional hemodialysis access.

J Vasc Access 2018 Dec 6:1129729818815327. Epub 2018 Dec 6.

Korea University Anam Hospital, Seoul, Republic of Korea.

Purpose:: To evaluate the feasibility and the outcomes of transjugular percutaneous endovascular treatment of dysfunctional hemodialysis access in patients with chronic kidney disease.

Methods:: A total of 50 transjugular treatments in 38 patients with arteriovenous fistulas or arteriovenous grafts from September 2011 to May 2015 were included in this study. Medical records and angiographies were retrospectively reviewed. Read More

View Article
December 2018
6 Reads
1.017 Impact Factor

Tei index is associated with survival in cirrhosis patients treated with transjugular intrahepatic portosystemic shunt.

Echocardiography 2018 Dec 1. Epub 2018 Dec 1.

Department of Ultrasound, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Background: Transjugular intrahepatic portosystemic shunt (TIPS) is the method of choice for the treatment of portal hypertension. The Tei index is the most sensitive indicator of myocardial function.

Design: This study enrolled 31 patients with cirrhosis who underwent TIPS and were followed up over a median period of 34 months (range 2-60 months). Read More

View Article
December 2018
1 Read

Changes in arterial oxygenation after portal decompression in Budd-Chiari syndrome patients with hepatopulmonary syndrome.

Eur Radiol 2018 Nov 30. Epub 2018 Nov 30.

Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.

Objectives: To evaluate the changes in arterial oxygenation after portal decompression in Budd-Chiari syndrome (BCS) patients with hepatopulmonary syndrome (HPS).

Methods: From June 2014 to June 2015, all patients with BCS who underwent balloon angioplasty or transjugular intrahepatic portosystemic shunt (TIPS) creation at our institution were eligible for inclusion in this study. Arterial blood gas analysis was performed with the patient in an upright position and breathing room air at 2-3 days and 1 and 3 months after the procedure. Read More

View Article
November 2018
5 Reads

Transjugular Removal of a Retained Intraportal Procurement Cannula in a Liver Transplant Recipient.

J Vasc Interv Radiol 2018 Dec;29(12):1778-1780

Division of Transplantation, Department of Surgery, University of Minnesota Medical School, Mayo Mail Code 195, 420 Delaware Street SE, Minneapolis, MN 55455.

View Article
December 2018

Gastrointestinal Bleeding Secondary to Portal Hypertensive Duodenopathy in a Patient with Decompensated Liver Cirrhosis.

Case Rep Gastrointest Med 2018 18;2018:9430701. Epub 2018 Oct 18.

Department of Gastroenterology and Hepatology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.

With alcoholic cirrhosis and nonalcoholic fatty liver disease continuously on the rise in the United States, there is also a corresponding rise in portal hypertension. Portal hypertensive duodenopathy (PHD) is a complication of portal hypertension not commonly seen in cirrhotic patients. We present a case of a 46-year-old man who presented with decompensated liver cirrhosis secondary to gastrointestinal bleed. Read More

View Article
October 2018
4 Reads

Stepwise evaluation of liver sectors and liver segments by endoscopic ultrasound.

World J Gastrointest Endosc 2018 Nov;10(11):326-339

Department of Gastroenterology, Sanjay Gandhi Post Graduate Institute, Lucknow 226014, Uttar Pradesh, India.

The liver has eight segments, which are referred to by numbers or by names. The numbering of the segments is done in a counterclockwise manner with the liver being viewed from the inferior surface, starting from Segment I (the caudate lobe). Standard anatomical description of the liver segments is available by computed tomographic scan and ultrasonography. Read More

View Article
November 2018
3 Reads

Critical Care Management of Gastrointestinal Bleeding and Ascites in Liver Failure.

Semin Respir Crit Care Med 2018 Oct 28;39(5):566-577. Epub 2018 Nov 28.

Division of Gastroenterology and Hepatology, Center for Liver Diseases and Transplantation, Weill Cornell Medical College, New York, New York.

Gastrointestinal (GI) bleeding and ascites are two significant clinical events that frequently present in critically ill patients with chronic liver failure or decompensated cirrhosis. GI bleeding in patients with cirrhosis, particularly portal hypertensive-associated bleeding, carries a high short-term mortality (15-25%) and requires early initiation of a vasoactive agent and antibiotics as well as timely endoscopic management. Conservative transfusion strategies and adequate airway protection are also imperative to assist in bleeding control. Read More

View Article
October 2018
2 Reads

Rapid cardiac ventricular pacing to facilitate embolization of vein of Galen malformations: technical note.

Authors:

J Neurosurg Pediatr 2018 Oct 1:1-6. Epub 2018 Oct 1.

OBJECTIVEVein of Galen aneurysmal malformations (VGAMs) in infancy have a poor natural history if left untreated. Their high-flow nature can preclude safe and accurate therapeutic vessel occlusion and the risk of inadvertent pulmonary embolism is predominant. The authors describe the technique of rapid cardiac ventricular pacing for inducing transient hypotension to facilitate the controlled embolization of VGAMs. Read More

View Article
October 2018
1 Read

Transjugular intrahepatic portosystemic shunt as a bridge to liver transplant: Current state and future directions.

Transplant Rev (Orlando) 2018 Oct 31. Epub 2018 Oct 31.

Division of Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, United States; Division of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States; Yale Cancer Center, Yale School of Medicine, New Haven, CT, United States. Electronic address:

Liver transplantation is one of the mainstays of treatment for liver failure due to severe chronic liver disease. Bridging therapies, such as placement of a transjugular intrahepatic portosystemic shunt (TIPS), are frequently employed to control complications of portal hypertension such as ascites, hydrothorax, and variceal bleeding, and thereby reduce morbidity in patients awaiting transplant. There is no significant difference seen in either graft survival or patient survival between those receiving TIPS pre-transplant and those who do not, although those receiving TIPS placement on average have a longer waiting time on the transplant waitlist. Read More

View Article
October 2018
2 Reads

The Choice of Interventional Treatment of Gastric Variceal Hemorrhage: What Is Better?

Authors:
Moon Young Kim

Gut Liver 2018 11;12(6):611-612

Department of Internal Medicine and Cell Therapy and Tissue Engineering Center, Yonsei University Wonju College of Medicine, Wonju, Korea.

View Article
November 2018
1 Read

Virtual Hepatic Venous Pressure Gradient with CT Angiography (CHESS 1601): A Prospective Multicenter Study for the Noninvasive Diagnosis of Portal Hypertension.

Radiology 2018 Nov 20:180425. Epub 2018 Nov 20.

From the Chinese Portal Hypertension Diagnosis and Monitoring Study Group (CHESS), CHESS Frontier Center, Lanzhou University, Lanzhou, China (Xiaolong Qi); Hepatic Hemodynamic Laboratory, Institute of Hepatology, Nanfang Hospital, Southern Medical University, Guangzhou, China (Xiaolong Qi, Y.L., Chuan Liu, Y.X., J. Hui, Z. Liu, J. Hou); Department of Radiology (W.A., Changchun Liu), Department of General Surgery (R.Q., Z. Li), and Center for Therapeutic Research of Hepatocarcinoma (Y.Y.), 302 Hospital of PLA, Beijing, China; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, Beijing, China (F.L., L.W.); Department of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang, China (Xingshun Qi); Department of Hepatobiliary Surgery (B.P.) and Organ Transplant Center (X.H.), The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; Department of Gastroenterology and Hepatology, Beijing You'an Hospital, Capital Medical University, Beijing, China (H.D.); Key Laboratory of Molecular Imaging of Chinese Academy of Sciences, Institute of Automation, Chinese Academy of Sciences, Beijing, China (J.T.); and Department of Hepatobiliary Surgery, The Third People's Hospital of Shenzhen, Shenzhen, China (Z. Li).

Purpose To develop and validate a computational model for estimating hepatic venous pressure gradient (HVPG) based on CT angiographic images, termed virtual HVPG, to enable the noninvasive diagnosis of portal hypertension in patients with cirrhosis. Materials and Methods In this prospective multicenter diagnostic trial (ClinicalTrials.gov identifier: NCT02842697), 102 consecutive eligible participants (mean age, 47 years [range, 21-75 years]; 68 men with a mean age of 44 years [range, 21-73 years] and 34 women with a mean age of 52 years [range, 24-75 years]) were recruited from three high-volume liver centers between August 2016 and April 2017. Read More

View Article
November 2018
6 Reads

Gross Total Resection of a Jugular Foramen Thyroid Medullary Metastasis via a Transjugular Transsigmoid Approach.

J Neurol Surg B Skull Base 2018 Dec 25;79(Suppl 5):S424-S425. Epub 2018 Sep 25.

Department of Neurological Surgery, University of Wisconsin Medical School, Madison, Wisconsin, United States.

Surgical resection of jugular foramen tumors poses a significant challenge to skull base surgeons with the selection of an appropriate surgical approach, a matter of some debate. Jugular foramen metastatic tumors may mimic paragangliomas, and in some selected cases surgical resection is needed. In this video, we demonstrate the microsurgical gross total resection of a jugular foramen tumor via a postauricular trans-jugular trans-sigmoid approach. Read More

View Article
December 2018
3 Reads

Systematic review and meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis.

Aliment Pharmacol Ther 2018 Nov 18. Epub 2018 Nov 18.

Swiss Liver Center, Hepatology, University Clinic for Visceral Surgery and Medicine, Inselspital, Department of Biomedical Research, University of Bern, Berne, Switzerland.

Background: Transjugular intrahepatic portosystemic shunt has been increasingly used in patients with portal vein thrombosis to obtain patency, but evidenced-based decisions are challenging.

Aim: To evaluate published data on efficacy and safety of endovascular therapy in portal vein thrombosis.

Methods: Systematic search of PubMed, ISI, Scopus, and Embase for studies (in English, until October 2017) reporting feasibility, safety, 12-month portal vein recanalisation, transjugular intrahepatic portosystemic shunt patency, and survival in patients with benign portal vein thrombosis undergoing endovascular treatment. Read More

View Article
November 2018
3 Reads

Percutaneous extrahepatic splenomeso-caval shunt creation in a patient with portal vein thrombosis after Whipple procedure.

Clin Imaging 2019 Jan - Feb;53:221-224. Epub 2018 Oct 23.

Division of Vascular and Interventional Radiology, Department of Radiology, Mayo Clinic, Rochester, MN, USA.

A 72-year-old male presented with refractory ascites secondary to portal vein occlusion with cavernomatous transformation following pancreaticoduodenectomy (Whipple procedure). Due to the unfavorable anatomy, transjugular intrahepatic portosystemic shunt was not an option. However, given patency of the spleno-mesenteric confluence and absence of the pancreatic head after the Whipple procedure, a splenomeso-caval shunt was successfully created using a transjugular-transsplenic rendezvous technique. Read More

View Article
October 2018
1 Read

Timing of Transjugular Intrahepatic Portosystemic Stent-shunt in Budd-Chiari Syndrome: A UK Hepatologist's Perspective.

J Transl Int Med 2018 Sep 9;6(3):97-104. Epub 2018 Oct 9.

Liver Unit, Queen Elizabeth Hospital, Birmingham, UK.

Budd-Chiari syndrome (BCS) is a rare but fatal disease caused by the obstruction in hepatic venous outflow tract (usually by thrombosis) and is further classified into two subtypes depending on the level of obstruction. Patients with BCS often have a combination of prothrombotic risk factors. Clinical presentation is diverse. Read More

View Article
September 2018
4 Reads

Does colectomy affect the progression of primary sclerosing cholangitis? A systematic review and meta-analysis.

Gastroenterol Hepatol Bed Bench 2018 ;11(4):277-283

Department of Gastroenterology, Bedford Hospital South Wing, Kempston Road, Bedford MK42 9DJ, United Kingdom.

Aim: The aim of this systematic review was to determine if the human colon, through the lower gut-liver axis, drives PSC activity by assessing the progression of the disease in patients with and without colectomy for colonic disease.

Background: The gut-liver axis is involved in the pathogenesis of liver disease. Abnormal immune-mediated responses to intestinal microbiome are implicated in primary sclerosing cholangitis (PSC) however the mechanisms remain poorly understood. Read More

View Article
January 2018
1 Read

Early TIPS failure in association with left mesenterico-gonadal spontaneous portosystemic venous shunt; a case report.

Clin Imaging 2019 Jan - Feb;53:200-203. Epub 2018 Oct 27.

Department of Radiology, University of Kentucky Chandler Medical Center, Lexington, KY, United States of America. Electronic address:

Transjugular intrahepatic portosystemic shunt (TIPS) periprocedural thrombosis rates have fallen significantly since the introduction of polytetrafluoroethylene-covered stent grafts. We present a case of a cirrhotic patient with portal hypertension presenting with early TIPS thrombosis in association with an underlying competing spontaneous left mesenterico-gonadal venous shunt, an uncommon variant of spontaneous portal systemic shunt (SPSS). The patient presented with bleeding distal duodenal varices refractory to endovascular therapy, and although a successful TIPS procedure was performed for this indication, early thrombosis was determined by follow-up abdominopelvic computed tomographic angiography (CTA) scan. Read More

View Article
October 2018
3 Reads

Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study.

Gut 2018 Nov 10. Epub 2018 Nov 10.

Department of Liver Diseases and Digestive Interventional Radiology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.

Objectives: Early placement of transjugular intrahepatic portosystemic shunt (TIPS) has been shown to improve survival in high-risk patients (Child-Pugh B plus active bleeding at endoscopy or Child-Pugh C 10-13) with cirrhosis and acute variceal bleeding (AVB). However, early TIPS criteria may overestimate the mortality risk in a significant proportion of patients, and the survival benefit conferred by early TIPS in such patients has been questioned. Alternative criteria have been proposed to refine the criteria used to identify candidates for early TIPS. Read More

View Article
November 2018
5 Reads

Excellent long-term outcomes of endovascular treatment in budd-chiari syndrome with hepatic veins involvement: A STROBE-compliant article.

Medicine (Baltimore) 2018 Oct;97(43):e12944

Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University.

This study aimed to evaluate the long-term efficacy and safety of percutaneous transhepatic balloon angioplasty (PTBA) and transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the treatment of Budd-Chiari syndrome (BCS) with hepatic veins involvement. Between June 2008 and August 2016, a total of 60 BCS patients with hepatic vein involvement in our department were enrolled in this study. Thirty-three cases underwent hepatic vein balloon angioplasty in PTBA Group and 27 cases underwent TIPSS. Read More

View Article
October 2018
4 Reads

The Feasibility of Using Volumetric Phase-Contrast MR Imaging (4D Flow) to Assess for Transjugular Intrahepatic Portosystemic Shunt Dysfunction.

J Vasc Interv Radiol 2018 Dec 3;29(12):1717-1724. Epub 2018 Nov 3.

Department of Radiology, Washington University School of Medicine, St. Louis, Missouri.

Purpose: To demonstrate the feasibility of detecting patency, stenosis, or occlusion of transjugular intrahepatic portosystemic shunt (TIPS) with four-dimensional (4D) flow MR imaging.

Materials And Methods: Sequential adult patients with TIPS were eligible for enrollment. Volumetric phase-contrast sequence was used to image TIPS. Read More

View Article
December 2018

Cost-Effectiveness of Transjugular Intrahepatic Portosystemic Shunt versus Large-Volume Paracentesis in Refractory Ascites: Results of a Markov Model Incorporating Individual Patient-Level Meta-Analysis and Nationally Representative Cost Data.

J Vasc Interv Radiol 2018 Dec 2;29(12):1705-1712. Epub 2018 Nov 2.

Department of Interventional Radiology, University of Washington Medical Center, 1959 NE Pacific Street, Seattle, WA 98195.

Purpose: To compare relative cost-effectiveness of serial large-volume paracentesis (LVP) and transjugular intrahepatic portosystemic shunt (TIPS) creation for treatment of refractory ascites.

Materials And Methods: A decisional Markov model was developed to estimate payer cost and quality-adjusted life-ears (QALYs) associated with LVP and TIPS treatment strategies for cirrhotic patients with refractory ascites. Survival estimates were derived from an individual patient-level meta-analysis of prospective randomized clinical trials. Read More

View Article
December 2018
6 Reads

Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension-Induced Refractory Ascites Due to Metastatic Carcinomatous Liver Disease.

J Vasc Interv Radiol 2018 Dec 2;29(12):1713-1716. Epub 2018 Nov 2.

Department of Radiology, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. Electronic address:

Three patients with a medical history of breast carcinoma and metastatic carcinomatous liver disease associated with severe portal hypertension and refractory ascites are presented. Transjugular intrahepatic portosystemic shunt creation was considered as a palliative treatment option and a valuable alternative to regular paracenteses in these patients. In 2 of the 3 patients, the refractory ascites was controlled for several months without need for paracentesis, and subsequently transjugular intrahepatic portosystemic shunt may provide valuable palliation and ascites control in patients with refractory ascites due to breast cancer-induced pseudocirrhosis. Read More

View Article
December 2018
3 Reads

Efficacy and safety of EUS-guided liver biopsy: a systematic review and meta- analysis.

Gastrointest Endosc 2018 Oct 30. Epub 2018 Oct 30.

Division of Gastroenterology and Hepatology, University of Utah School of Medicine, Salt Lake City, Utah, USA. Electronic address:

Background And Aims: EUS-guided liver biopsy (LB) is an emerging technique to conventional percutaneous (PC) or transjugular (TJ) approaches. Recent studies have reported that EUS-guided LB (EUS-LB) may have a better safety profile compared with PC-LB or TJ-LB without compromising diagnostic yield, and the outcomes are varied with respect to the types of biopsy needles. We performed a systematic review and meta-analysis to estimate the diagnostic yield, specimen adequacy, and adverse events associated with EUS-LB. Read More

View Article
October 2018
3 Reads

Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS).

United European Gastroenterol J 2018 Nov 15;6(9):1380-1390. Epub 2018 Aug 15.

Department of Medicine II, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Background And Objective: Treatment with proton pump inhibitors (PPIs) has been associated with development of hepatic encephalopathy (HE). As development of HE is a major complication after implantation of a transjugular intrahepatic portosystemic shunt (TIPS), we hypothesized that PPI treatment may be associated with a higher risk of post-TIPS HE.

Methods: We analyzed data of 397 patients with liver cirrhosis who received de novo TIPS implantation at the University Medical Center Freiburg, Germany. Read More

View Article
November 2018
5 Reads

Long-Term Outcome of Veno-Occlusive Disease After Liver Transplant: A Retrospective Single-Center Experience.

Exp Clin Transplant 2018 Oct 24. Epub 2018 Oct 24.

From the Department of General Surgery, Liver Transplant Center, A.O.U. Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.

Objectives: Veno-occlusive disease after liver transplant has been sporadically reported, and significant uncertainty exists concerning the best treatment and the long-term outcomes. Here, we reviewed our experience to evaluate clinical presentation, treatment, and the long-term outcomes of these patients.

Materials And Methods: Between 2000 and 2015, 2165 patients underwent liver transplant at our center. Read More

View Article
October 2018
3 Reads

Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.

Cochrane Database Syst Rev 2018 10 31;10:CD001023. Epub 2018 Oct 31.

Department of Surgery, University of Pretoria, Pretoria, South Africa, 0001.

Background: Variceal haemorrhage that is refractory or recurs after pharmacologic and endoscopic therapy requires a portal decompression shunt (either surgical shunts or radiologic shunt, transjugular intrahepatic portosystemic shunt (TIPS)). TIPS has become the shunt of choice; however, is it the preferred option? This review assesses evidence for the comparisons of surgical portosystemic shunts versus TIPS for variceal haemorrhage in people with cirrhotic portal hypertension.

Objectives: To assess the benefits and harms of surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt (TIPS) for treatment of refractory or recurrent variceal haemorrhage in people with cirrhotic portal hypertension. Read More

View Article
October 2018
10 Reads

Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: a retrospective study.

BMC Gastroenterol 2018 Oct 26;18(1):156. Epub 2018 Oct 26.

Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe Donglu, Zhengzhou, 450052, Henan, China.

Background: Hepatic veno-occlusive disease (HVOD) caused by Gynura segetum has been increasingly reported in China in recent years. The aim of this retrospective study was to identify independent prognostic markers for survival in patients with Gynura segetum-induced HVOD and to evaluate the effect of anticoagulants and transjugular intrahepatic portosystemic shunt (TIPS) on survival rate.

Methods: Clinical data including symptoms, signs, imaging characteristics, laboratory test results, results of liver tissue biopsies, type of treatment during follow-up and clinical outcomes were collected. Read More

View Article
October 2018
9 Reads
2.370 Impact Factor

Precision Onion Skinning Technique for Transjugular Intrahepatic Portosystemic Shunt Revision.

Cureus 2018 Aug 22;10(8):e3180. Epub 2018 Aug 22.

Interventional Radiology, University of Florida Health, Jacksonville, USA.

A transjugular intrahepatic portosystemic shunt is the standard of care for complications of portal hypertension, such as variceal bleeding, refractory ascites, and hepatic hydrothorax. Hepatic encephalopathy, hepatic insufficiency, and right heart failure are the major complications after shunt creation. If medical management is unsuccessful, the interventionalist is consulted to close/revise the shunt. Read More

View Article
August 2018
5 Reads

Pre-emptive TIPS for acute variceal bleed: Choose your patient well!

Authors:
Sandeep Satsangi

Hepatology 2018 Oct 24. Epub 2018 Oct 24.

B.G.S Gleneagles Global Hospital, Global Integrated Liver Care, 67, Uttarahalli Road, Fort Kengeri, Bangalore, Karnataka, India.

I read with great interest the manuscript published by Procopet B et al. The authors have eloquently demonstrated the survival benefit of pre-emptive transjugular intrahepatic portosystemic shunt (p-TIPS) placement in patients with Child C cirrhosis presenting with acute variceal bleed (AVB). This article is protected by copyright. Read More

View Article
October 2018
20 Reads
11.050 Impact Factor

Agitation thrombolysis combined with catheter-directed thrombolysis for the treatment of non-cirrhotic acute portal vein thrombosis.

World J Gastroenterol 2018 Oct;24(39):4482-4488

Department of Interventional Radiology, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang 471000, Henan Province, China.

Aim: To evaluate the safety and efficacy of agitation thrombolysis (AT) combined with catheter-directed thrombolysis (CDT) for the treatment of non-cirrhotic acute portal vein thrombosis (PVT).

Methods: Nine patients with non-cirrhotic acute PVT who underwent AT combined with CDT were analyzed retrospectively. Portography was carried out the transjugular intrahepatic portosystemic (commonly known as TIP) or percutaneous transhepatic (commonly known as PT) route, followed by AT combined with CDT. Read More

View Article
October 2018
4 Reads

Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture.

World J Gastroenterol 2018 Oct;24(39):4419-4427

Department of Gastroenterology, "Grigore T Popa" University of Medicine and Pharmacy, Iași 700115, Romania.

Portal vein thrombosis (PVT) is a frequent and serious complication in patients with liver cirrhosis (LC). Recently, a new classification of PVT was proposed, although the functional component was not completed included. The status of liver disease (compensated/decompensated) should be added to this classification. Read More

View Article
October 2018
3 Reads

Renal Failure in Patients with Liver Cirrhosis: Novel Classifications, Biomarkers, Treatment.

Visc Med 2018 Aug 14;34(4):246-252. Epub 2018 Aug 14.

Department of Internal Medicine II, University of Saarland, Homburg/Saar, Germany.

Renal failure is a severe complication in patients with liver cirrhosis. It is associated with increased mortality and morbidity. Diagnosis is a challenge because it is mainly based on serum creatinine, which does not seem to be an ideal measure of renal function in cirrhosis. Read More

View Article
August 2018
12 Reads

Acquired factor VII deficiency causing severe bleeding disorder secondary to AL amyloidosis of the liver.

Hematol Rep 2018 Sep 24;10(3):7235. Epub 2018 Sep 24.

Division of Medical Oncology & Hematology.

A 52 year-old male presented with neck pain after undergoing thyroidectomy for a goiter three weeks prior which was complicated by a neck hematoma requiring evacuation. Computed tomography (CT) scan showed a neck hematoma requiring evacuation and he received desmopressin with cessation of bleeding. Coagulation studies were normal. Read More

View Article
September 2018
2 Reads

[Follow-up study of 116 cases of transjugular intrahepatic portosystemic shunt in the treatment of cirrhotic portal hypertension].

Zhonghua Gan Zang Bing Za Zhi 2018 Aug;26(8):596-600

Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430000, China.

To investigate the incidence rate of transjugular intrahepatic portosystemic shunt (TIPS) complications in the treatment of cirrhotic portal hypertension, and analyze the cause of complication to management methods. Data of 116 patients obtained from Zhongnan Hospital of Wuhan University were retrospectively analyzed. Portal venous pressure, routine blood test, coagulation test, liver and kidney function test, ammonia blood test, imaging and endoscopy reports were collected before and after procedure. Read More

View Article
August 2018
1 Read

Benefits of Early Treatment for Patients with Hepatic Myelopathy Secondary to TIPS: A Retrospective Study in Northern China.

Sci Rep 2018 Oct 12;8(1):15184. Epub 2018 Oct 12.

Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.

Transjugular intrahepatic portosystemic shunt (TIPS) is an effective therapy for reducing portal pressure. Hepatic myelopathy (HM), a rare complication of chronic liver diseases, remains obscure in terms of treatment and prognosis. We aimed to determine an optimal treat strategy for patients with HM after TIPS. Read More

View Article
October 2018
2 Reads

Race and Gradient Difference Are Associated with Increased Risk of Hepatic Encephalopathy Hospital Admission After Transjugular Intrahepatic Portosystemic Shunt Placement.

J Clin Exp Hepatol 2018 Sep 30;8(3):256-261. Epub 2017 Dec 30.

Transplant and Advanced Liver Disease Center, Banner University Medical Center, Phoenix, AZ, USA.

Background/aims: Hepatic encephalopathy (HE) is a well-recognized complication of transjugular intrahepatic portosystemic shunt (TIPS) placement. The aim of this investigation was to evaluate incidence and predictors of post-TIPS HE necessitating hospital admission in a non-clinical trial setting.

Methods: We performed a retrospective cohort study identifying 273 consecutive patients undergoing TIPS from 2010 to 2015 for any indication; 210 met inclusion/exclusion criteria. Read More

View Article
September 2018
2 Reads

Technical success and outcomes in pediatric patients undergoing transjugular intrahepatic portosystemic shunt placement: a 20-year experience.

Pediatr Radiol 2018 Oct 6. Epub 2018 Oct 6.

Department of Radiology, Division of Vascular and Interventional Radiology, University of Michigan Health System, 1500 E. Medical Center Drive, Ann Arbor, MI, 48109, USA.

Background: Transjugular intrahepatic portosystemic shunt (TIPS) placement has been extensively studied in adults. The experience with TIPS placement in pediatric patients, however, is limited.

Objective: The purpose of this study was to report technical success and clinical outcomes in pediatric patients undergoing TIPS placement. Read More

View Article
October 2018
5 Reads

Shear wave elastography prior to transjugular intrahepatic portosystemic shunt may predict the decrease in hepatic vein pressure gradient.

Abdom Radiol (NY) 2018 Oct 4. Epub 2018 Oct 4.

Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

Background: Transjugular intrahepatic portosystemic shunt (TIPS) is a procedure used to treat portal hypertension complications. Our aim was to evaluate liver and spleen stiffness measurement (LSM and SSM, respectively) changes using acoustic radiation force impulse imaging (ARFI) in comparison to Child-Pugh scores for predicting hepatic venous pressure gradient (HVPG) decreases after TIPS implantation.

Methods: This prospective study included 31 consecutive clinically significant portal hypertension patients with TIPS indication. Read More

View Article
October 2018
2 Reads

Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.

Virol J 2018 10 1;15(1):151. Epub 2018 Oct 1.

Department of Radiology, China-Japan Union Hospital of Jilin University, 126 Xintai St, Changchun, 130022, Jilin Province, China.

Background: Transjugular intrahepatic portosystemic shunt (TIPS) procedure has played a vital role in management of portal hypertension. Thus, we aimed to investigate the natural history, long-term clinical outcome, predictors of survival in viral hepatitis related cirrhotic patients post-TIPS.

Method: A total of 704 patients with complete followed-up data were enrolled, and clinical characteristics of patients were collected and analyzed. Read More

View Article
October 2018
6 Reads

Percutaneous atrial septal defect closure through femoral and transjugular approaches in patients with interrupted inferior vena cava.

J Cardiol Cases 2018 Sep 9;18(3):106-109. Epub 2018 Jun 9.

Cardiovascular Center, University Medical Center, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam.

Femoral venous approach is the classic route of percutaneous atrial septal defect (ASD) closure. But in patients with interrupted inferior vena cava (IVC) with azygos continuation the normal connection is lost rendering transcatheter intervention more complicated and innovative approaches should be sought. Transhepatic approach has been used with success but this approach is technically demanding and could lead to major complications. Read More

View Article
September 2018

Treatment of peristomal hemorrhage: A review of outcomes and comparison of two minimally invasive techniques.

Diagn Interv Imaging 2018 Dec 29;99(12):793-799. Epub 2018 Sep 29.

Department of Radiology, University of Minnesota, Minneapolis, MN 55455, USA.

Purpose: The purpose of this study was to review and compare outcomes between percutaneous sclerotherapy and transjugular intrahepatic portosystemic shunt (TIPS) treatments in patients with peristomal variceal bleeding.

Materials And Methods: Ten patients who underwent sclerotherapy (n = 3 patients), TIPS placement (n = 5 patients) or both (n= 2 patients) for peristomal variceal bleeding were retrospectively reviewed. There were 6 women and 4 men, with a mean age of 62. Read More

View Article
December 2018
2 Reads

Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study.

EBioMedicine 2018 Oct 27;36:151-158. Epub 2018 Sep 27.

CHESS Group, Hepatic Hemodynamic Lab, Institute of Hepatology, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China; Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China; CHESS Frontier Center, Lanzhou University, Lanzhou, China. Electronic address:

Clinically significant portal hypertension (CSPH) is associated with an incremental risk of esophageal varices and overt clinical decompensations. However, hepatic venous pressure gradient (HVPG) measurement, the gold standard for defining CSPH (HVPG≥10 mm Hg) is invasive and therefore not suitable for routine clinical practice. This study aims to develop and validate a radiomics-based model as a noninvasive method for accurate detection of CSPH in cirrhosis. Read More

View Article
October 2018
7 Reads

Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.

Hepatobiliary Pancreat Dis Int 2018 Dec 7;17(6):517-523. Epub 2018 Sep 7.

Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, China. Electronic address:

Background: Treatment options for patients with cavernous transformation of portal vein (CTPV) are limited. This study aimed to evaluate the feasibility, efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) to prevent recurrent esophageal variceal bleeding in patients with CTPV.

Methods: We retrospectively analyzed 67 consecutive patients undergone TIPS from January 2011 to December 2016. Read More

View Article
December 2018
7 Reads

Snare technique for endovascular retrieval of coil extending to the atrium after embolization of a dural arteriovenous fistula.

Acta Neurochir (Wien) 2018 Nov 24;160(11):2177-2186. Epub 2018 Sep 24.

Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, China International Neuroscience Institute (China-INI), Beijing, China.

Background: No data exist regarding retrieval of displaced or stretched coil extending to the right atrium after endovascular embolization of cerebrovascular diseases. We describe a snare technique for retrieval of a displaced coil extending to the right atrium after embolization of dural arteriovenous fistula (DAVF).

Methods: A 35-year-old female with a DAVF underwent transjugular coil embolization that failed with displaced coil extending to the right atrium at an outside hospital. Read More

View Article
November 2018
10 Reads

Outcomes after placement of a SX-ELLA oesophageal stent for refractory variceal bleeding-A national multicentre study.

Liver Int 2018 Sep 24. Epub 2018 Sep 24.

Divsion of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

Background: Current guidelines favour the use of bleeding stents over balloon tamponade (BT) for refractory variceal bleeding (VB) from oesophageal varices. However, data on the efficacy and safety of self-expandable metal SX-ELLA Danis stents (SEMS) are limited.

Methods: Cirrhotic patients receiving SEMS for VB at four tertiary care centres were included in this retrospective multicentre study. Read More

View Article
September 2018
5 Reads

The Transjugular Approach: An Alternative Route to Improve Ablation Success in Right Anteriorly and Anterolaterally-Located Supraventricular Tachycardia Substrates in Children.

Pediatr Cardiol 2018 Sep 22. Epub 2018 Sep 22.

Mehmet Akif Ersoy Gogus Kalp Damar Cerrahisi Egitim Arastirma Hastanesi, Istanbul, Turkey.

Catheter ablation via the femoral vein has been widely used in children. However, in certain conditions, an alternative vascular access is required for a successful ablation. Herein we reported that, accessory pathways (APs) and ectopic foci which reside right anterior and anterolateral to tricuspid valve orifice can be safely and effectively ablated with transjugular venous approach. Read More

View Article
September 2018
13 Reads

Femoral versus jugular access for Denali Vena Cava Filter placement: Analysis of fluoroscopic time, filter tilt and retrieval outcomes.

Clin Imaging 2018 Nov - Dec;52:337-342. Epub 2018 Sep 19.

Department of Radiology, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea.

Purpose: To analyze relevant metrics involved in Denali Vena Cava Filter placement via different venous access sites.

Materials And Methods: Patients with Denali filters inserted between March 2017 and February 2018 were retrospectively analyzed. Pre-procedural and pre-retrieval computed tomography (CT) were reviewed. Read More

View Article
September 2018

Catheter-Directed Thrombolysis for Portal Vein Thrombosis in Children: A Case Series.

J Vasc Interv Radiol 2018 Nov 17;29(11):1578-1583. Epub 2018 Sep 17.

Section of Interventional Radiology, Department of Radiology, Seattle Children's Hospital, 4800 Sand Point Way NE, Seattle, WA 98105; Department of Radiology, University of Washington, Seattle, Washington.

Purpose: To describe safety and efficacy of catheter-directed thrombolysis (CDT) for portal vein thrombosis (PVT) in children.

Materials And Methods: Retrospective review was performed of 10 consecutive patients (7 girls, 3 boys; mean age 11.9 y; range, 3-17 y) with PVT undergoing CDT at a single tertiary children's hospital between August 2005 and March 2016. Read More

View Article
November 2018
1 Read
2.150 Impact Factor

Bile leak after transjugular liver biopsy in a cholecystectomy patient.

Radiol Case Rep 2018 Dec 14;13(6):1203-1206. Epub 2018 Sep 14.

Diagnostic Radiology and Nuclear Medicine Department, University of Maryland Medical Center, 33 S Greene Street, Baltimore, MD 21201, USA.

Introduction: Transjugular liver biopsy (TJLB) is a minimally invasive procedure performed to obtain hepatic tissue in patients whom standard percutaneous liver biopsy is contraindicated due to abnormal coagulation profile and/or severe ascites. Additionally, it has the advantage of simultaneously measuring the hepatic venous pressures.

Case Presentation: 61-year-old male with history of pulmonary fibrosis, cholecystectomy and Hepatitis C underwent transjugular liver biopsy (TJLB) as part of his lung transplant workup. Read More

View Article
December 2018
3 Reads